Allogeneic bone marrow transplantation (BMT) has been successfully used for the treatment of several hematological malignancies; however, it is associated with transplant-related toxicities such as functional impairment and muscle weakness. In order to analyze how an exercise program may influence muscle strength in patients undergoing BMT, we carried out a prospective study assessing patients from the pre-BMT phase to 16 weeks post-BMT. In all, 18 patients underwent three trials: (1) pre-BMT, (2) after marrow engraftment, and (3) 6 weeks after trial 2. After trial 2, the patients were randomized in a control group (CG) or treatment group (TG), which received a 6-week exercise program with active exercise, muscle stretching and treadmill walking. The results obtained in trial 1 showed similar values for CG and TG, as both groups had muscle strength lower than normal patterns based on data concerning age, sex and weight. In trial 2, CG and TG showed similarly decreased values. In trial 3, TG showed values higher than CG for all muscle groups tested. These results suggest that the exercise program was efficient in promoting an increase of muscle strength after allogeneic BMT.
ation Allogeneic bone marrow transplantation (BMT) has been the treatment of choice for patients with a variety of hematological diseases, providing them with good clinical results and a longer life expectancy. However, BMT is associated with transplant-related toxicities such as functional impairment, which compromise full rehabilitation and also contribute to the inherent morbidity associated with the procedure itself. 1 It has been found that fatigue and weakness in accomplishing daily living activities are the primary symptoms of functional impairment. 2 It has been reported that these symptoms are related to high-dose chemotherapy for the treatment of breast 3, 4 and prostate cancer patients. 5 It has been hypothesized that the malignancy may influence this muscular fatigue as such fatigue has been reported in other diseases. It is evident that in cancer patients, physical, biochemical and psychological processes are interwoven. Fatigue-inducing factors that have been proposed include the primary impact of cancer tissue on organic systems, higher cytokine production and changes in the energy-transforming process. 6 The cancer therapy itself, such as chemotherapy or radiotherapy, damage healthy cells throughout the body leading to side effects including nausea, emesis, decreased nutritional intake and anemia. Higher fatigue levels associated with decreased levels of activity and lengthened bed rest contribute to muscular catabolism and atrophy. 7 These side effects lead patients who have undergone allogeneic BMT into a state of functional deprivation. Graft-versus-host disease (GVHD) may be associated with muscular fiber necrosis. 8, 9 Case reports have suggested that muscle toxicity is related to the use of cyclosporin A 10, 11 and glucocorticoids, [12] [13] [14] [15] [16] which are often used in the treatment of GVHD. Muscular atrophy and weakness have also been reported in cardiac 17 and renal transplant recipients, 18 who are receiving other immunosuppressive drug treatments without chemotherapy. Despite the severity of this problem, research regarding muscle strength in BMT recipients is difficult to find in the literature.
Muscle strength assessment is a crucial component for physical therapy diagnosis and treatment of patients with fatigue and weakness. The degree to which a patient's muscle strength is impaired, however, can only be established if the clinician is provided with appropriate, objective normal values. 19 Manual muscle tests are standardized and very useful in clinical settings, but fail to provide such precise values as would a test using a device such as a dynamometer, which provides quantitative data. Hand-held dynamometers are mostly used to assess muscle performance even in patients with neuromuscular diseases, who are severely compromised and may not tolerate aggressive or invasive evaluations. 20 The maximal voluntary isometric contraction test is the simplest method using a hand-held dynamometer because it holds the velocity of joint motion and muscle length constant. 21 There are few case reports in the literature regarding respiratory muscle strength [22] [23] [24] and the serial level of muscle degradation enzymes. 25, 26 In the literature there are reports that suggest that exercise programs improve physical performance in patients undergoing BMT, 27 but these studies have evaluated other parameters and did not directly address muscle strength. The purpose of this study was to analyze how an exercise program may affect the muscle strength of patients undergoing BMT.
Materials and methods

Subjects
A total of 32 patients had initially been selected for this study, 10 of them died, four were excluded because of clinical complications and 18 concluded the study.
The criteria for inclusion were as follows: adult recipients, controlled clinical status, absence of pain and musculoskeletal or neurological disturbances, and no evidence of cardiovascular, pulmonary or motor function impairment. These clinical conditions were confirmed by a normal electrocardiogram, echocardiogram and pulmonary function tests, which were assessed in the pre-BMT period. The Ethics Committee of the University of Sa˜o Paulo approved the study and informed consent was obtained from all participants.
All subjects underwent the muscle strength test in three distinct trials: (trial 1) pre-BMT, (trial 2) after bone marrow engraftment and (trial 3) 6 weeks after trial 2. After trial 2, they were randomly assigned to a control group (CG) or a treatment group (TG). The TG received an exercise program with active exercises, muscle stretching and a walking-based program on a treadmill lasting 6 weeks. The characteristics of the groups are described in Table 1 .
Instrumentation
The muscle strength test was performed with a Chatillon Inc. strain-gauge dynamometer. The dynamometer incorporated a load cell and had a digital display. The dynamometer was set to be read in Newtons (N), wherein the limits ranged from 0 to 2.250 N.
Procedure
Maximal isometric voluntary strength tests (MIVS) from four muscle groups of the upper limbs and five muscle groups of the lower limbs were collected to assess the subject's muscle strength. A nonstretching strap was used to connect the dynamometer to the lower or upper limbs to be tested. The examiner always placed the dynamometer perpendicular to the movement axis.
The muscle groups that were assessed as well as the position of the joints and the dynamometer adopted in the tests were standardized according to Bohannon. 21 The dominant side (DM) of the body was first determined by asking the subject which hand and foot were preferred to throw and kick a ball. The contralateral side is known as the nondominant side (NDM). Once the subject and the dynamometer were placed in the proper position, the subject was asked to pull the dynamometer strap, building his or her maximal force so that he or she exerted the maximum strength sustained for 3 s. This procedure was repeated twice for each muscle group tested, and the first data collected were discharged as a patient learning procedure. The whole process of data collection was performed by the same examiner.
Exercise program
The exercise program was inspired by DIMEO 28 and was carried out daily, on weekdays, over 6 weeks. This exercise program was initiated during the inpatient period and was concluded in the outpatient facility. The exercise program comprised: (i) active range of motion exercises for shoulder, elbow, hip, knee and ankle; (ii) stretching exercises for hamstring, triceps surae and quadriceps muscles, and (iii) a modified treadmill walking program; a schedule of intervals for resting periods in the sitting position was needed because of the inherent critical condition of patients after BMT. This schedule progressed from five sets of 3 min of walking at a comfortable speed, with 3 min rest in between each set in the first week to two sets of 10 min of walking at a comfortable speed intercalated with 20 min walking at an accelerated speed in the 6th week ( Figure 1 ).
Each therapy session lasted 40 min. The patient was monitored during the exercise session by a Polar Sport Tester monitor to guarantee that he or she would work with a heart rate no higher than 70% of the maximal heart rate calculated by Karvonen's equation (220-age-HR basal+60/70%). The exercise session was postponed to the following day if the red blood cell count was above 10 mg/dl and/or platelets were above 20 000 cells/mg/dl.
Data analysis
Normalized ratio of strength was adopted to allow comparative analysis to provide a stable reference. For this normalization process, the collected data were divided according to literature references, using specific regression equations for each muscle tested. 21 It has been established that normalized ratio of strength values 41 represent a performance higher than normal, according to sex, age and weight patterns, and normalized ratio of strength values o1 represent a performance lower than normal. Average (x) and standard deviations (s.d.'s) were calculated for all data. A Student t-test was used to determine if there had been any differences between measurements obtained in the trials for the correlated populations (same group, in the three trials) and in the same trial for noncorrelated populations (different groups in the same trial). An analysis of variance (ANOVA) was used to determine comparisons among groups in the three trials. Statistical significance at a level of 0.50 was used.
Results
(1) Same trial, different groups: The outcomes of muscle strength, in trial 1, pre-BMT, were found to be similar between the two groups of patients, for all muscle groups tested, except the elbow flexors DM (P ¼ 0.042) and the hip abductors DM (P ¼ 0.035) where higher values were found in the CG. However, both the CG and the TG obtained values o1, indicating muscle strength lower than normal patterns for all muscles tested. In trial 2, post-BMT, both CG and TG showed similarly decreased values. In trial 3, TG showed higher values than CG, for all muscle groups tested, pointing to a significant difference for hip flexors NDM (P ¼ 0.011).
(2) Different trial, same group: In the comparison between trials 1 and 2, both CG and TG showed lower values for most of the analyzed muscle groups (Tables 2   and 3 ). On trials 2 and 3, the CG continued to reveal decreased values for all muscle groups analyzed, with statistical significance in the lower limb groups. The TG revealed significantly increased values for three out of eight upper limb muscle groups, and five out of 10 lower limb muscle groups.
Although both groups somehow achieved higher values when comparing trials 2 and 3, when comparing trials 1-3, we found that the TG was similar for all the muscle groups in the upper limb, indicating full recovery, with significantly decreased values for only two groups out of 10 in the lower limb muscle groups. In CG, it was found that seven out of eight upper limb muscle groups had significantly decreased values, and four out of 10 lower limb muscle groups also showed significantly decreased values. The ANOVA for the CG showed that the averages for trial 2 were closer to trial 3 than trial 1. Therefore, in TG, ANOVA showed that the averages of trial 2 were closer to trial 1 than to trial 3.
Discussion
Allogeneic BMT is a well-based therapy for treating oncohematological diseases resistant to conventional therapy. Further research into human histocompatibility has increased the success of engraftment, and the development of new immunosuppressive drugs has also allowed a greater control of adverse reactions, such as GVHD, making this procedure less aggressive.
Clinical experience of the authors has shown the need for a broader evaluation of physical conditions with muscle strength tests to quantify the losses in each phase of BMT. The maximum voluntary isometric strength test was chosen for this study because it is similar to manual tests regarding the standardization of measurement location, the stable maintenance of the lever arm and the capacity to detect changes in strength without requiring excessive effort. Moreover, the chosen method allowed the decisive advantage of applicability considering the severe clinical conditions of this group of patients.
The maximum voluntary isometric strength test can be performed with any kind of dynamometer, but the hand-held dynamometers afford several clinical advantages compared with isokinetic ones. They are portable, easy to use, can be performed in outpatient settings and enable the measurement of major muscle groups. The applicability is also superior when one wishes to evaluate the performance of the same patient in several phases of the treatment. 29, 20 Absolute values alone are of limited usefulness without normal strength values for comparison; for example, 20 N of elbow flexion may be strong or weak depending on the gender, age and size of the individual tested. 29 The normalized ratio of strength was used to make possible the interpretation of absolute strength values related to the values foreseen in the literature. 21, 19 It also made possible data comparison among patient groups of different sexes and weights and at different ages, and the evaluation of the BMT effect itself.
The results obtained in trial 1 represent the condition of the groups prior to BMT. The similarity among the groups was observed, referring to the nature of the disease, general and nutritional status (BMI) as well as muscle strength. However, both groups showed values o1, below the literature standard.
Such findings make one think that, although the patients all had good general status and no functional complaints, the presence of hematological disease can cause subclinical alterations in motor function, with disturbance of other mechanisms related to the voluntary recruitment of motor units.
Tilignac 30 inductively related effects of cytostatic agents on skeletal muscle protein turnover to a negative nitrogen balance, downregulated muscle proteosome dependent on proteolyis by a mechanism that includes reduced m-RNA levels, which is associated with a decrease in the bulk of muscle proteolysis to the major contractile compounds, actin and myosin. These effects were also observed in adult cancer patients after the administration of vinblastine, cisplatin and bleomycin. 31 In addition to this, Glaus 6 noted that fatigue is more frequent in periods of active neoplasic disease, when the patient's cachectic status compromises the energy consumption required to perform muscular contraction. It can, nevertheless, persist beyond the remission phase, in the absence of physiological mechanisms of fatigue, as the psychological mechanisms of nonmotivation, related to the severity of the disease prognosis.
The existential outlook of a person suffering from a potentially fatal disease may require him or her to withdraw, and use a coping mechanism expressed as a feeling of depression. On the other hand, if there is evidence for physical causes of fatigue, the unanswered question is whether this tiredness is a symptom of the disease or a symptom of a coping mechanism and depression, or whether it is a combination of both. The muscle strength decrease prior to BMT does not represent a pathologic state or a serious risk during life, but it reinforces the need for careful follow-up of these patients, considering that the use of some drugs, which are indirectly involved in this decrease, are necessary and fundamental for the success of the procedure.
In trial 2, there was a similar decrease in muscle strength in the upper and lower limb muscles with no statistical difference between the two groups. This finding shows that the change is global, compatible with the side effects of BMT itself. These symptoms have already been related in our previous study. 2 The authors consider that muscle weakness may not be related to drug effects. Cyclosporine and corticosteroids are the most common drugs used for GVHD prophylaxis and treatment. An acute form of corticosteroid-induced myopathy has been observed in patients with acutely severe asthma being treated with 3-4 mg/kg day, who show diffuse muscle weakness, rhabdomyolisis and marked elevation of creatinokinase as the main clinical features. 32 The chronic form of corticosteroid-induced myopathy was reported in patients with pathologic cardiac and pulmonary conditions who had received long-term corticosteroids. There is a wide time variation between the appearance of myopathy and administration, so the correlation is poor. The muscle weakness is insidious, symmetric, and has variable grades from no objective fall in muscle strength to difficulties in raising upper or lower limbs. 32, 12 In trial 3, there was an increase in muscle strength in the CG as well as in the TG. The absence of a significant difference in the intergroup comparison shows that the strength increase occurred in all patients, and could be attributed to the stabilization of their general clinical status by that time.
After discharge some patients may need weeks or months to regain their pretreatment level of fitness. The studies of DIMEO 7 show that the loss of performance observed after high-dose chemotherapy (HDC) can be at least partially prevented with exercise, and that starting rehabilitation immediately after HDC is possible without increasing morbidity.
The intragroup comparison of muscle strength change between trials 1 and 3 of the same group, represents the real gain or loss of values obtained at the post BMT, as related to the pre BMT. The greater number or the most expressive number of muscles with decreased strength in CG, as related to TG, concurs in that there has been a strength improvement in the latter. Such findings demonstrate the influence of exercises in TG rehabilitation, the subjects of which achieved a performance closer to the one obtained pre-BMT than did the CG.
Braith 33 had already associated the improvement in muscle strength with the use of early exercises in patients undergoing cardiac transplantation. This author demonstrated a 12% increase in the strength of knee extensor muscles in the training group against 2.1% in the control group, when compared to the pre-and post-transplant results.
The beneficial effects of exercises on muscular fatigue or weakness could be related to a greater release of androgens, corticoid antagonists; reduction of protein degradation and change in cell receptor capacities. The stimulus to normal metabolism acts in all sorts of fibers, even though it does not cause objective muscular hypertrophy. 16 Gait is the physical activity most known and better adapted to improvement in physical status, and it is considered safe from the cardiovascular and orthopedic point of view. Dimeo 28 has already successfully used a treadmill gait program for patients in post BMT, demonstrating an improvement in physical capacity, but to show their efficiency, that author supported his study with parameters other than muscle strength.
We have chosen to use a similar program, adapted to its purpose, adding exercises for the upper limbs and stretching. The intensity used in the exercise, which ranged from mild to moderate, proved to be adequate for the immediate post BMT phase, and for the muscle strength decrease observed in trial 2. This decrease in muscle strength could interfere with gait performance, regardless of the stable levels of hemoglobin required to perform the exercises.
We believe that the activity programs used in this treatment protocol acted as functional stimuli to muscle contraction, covering the summation of factors that produce strength decreases in patients in post BMT.
In spite of a direct comparison of these study data with those of Dimeo 28 being impaired owing to differences in method, it is complemented by the decrease in complaints of fatigue and the good tolerance to early exercise performance, making it possible to conclude that the proposed treatment program proved effective in promoting increased muscle strength after allogeneic BMT, considering that TG presented an earlier return to strength values similar to those obtained pre-BMT.
